This article was originally published about a month ago, on August 20, but there is a new push behind the stock, premised on the idea that “a ferocious short-seller ‘hit piece’” has suppressed the share price — “temporarily,” they believe. So we’re re-publishing our answer here for you, and I’ve added a deeper look into […]
Anyone have ideas? And has anyone bought the Project 5X subscription for $2500? https://m.riskhedge.com/the-109x-microcap?utm_campaign=RH-060&utm_content=060R01&utm_medium=EM&utm_source=rhd
Today we’re headed into the wild and woolly world of biotech once again, sniffing out the secret stock from a teaser pitch for Biotech Millionaire, edited by Chris Wood and Jake Weber over at Mauldin Economics ($1,795/yr, includes their Healthy Returns letter… and unlike most higher-cost letters these days, they actually offer a 30-day refund […]
High-end newsletter focused on small-cap biotech stocks, using what they call their CASH system to select recommended stocks (Catalysts, large Addressable market, good Science, and a potential Hype story). Wood also edits the “entry level” healthcare investment advisory Healthy Returns.
This article was originally published back in August, 2019 when we were getting lots of questions about Chris Wood’s teaser pitch — the ad is still largely the same, most of the hints and projections are identical and he still expects that February 2020 approval will send the stock soaring (yes, we’re still getting this […]
I’ve been knocked out by a non-coronavirus illness for the past couple days, and I have to tell you, that’s probably the best thing that could have happened for my sanity — watching the stock tickers fly by and freaking out at the constant stream of COVID-19 news is not the best way to keep […]
New “wealth and wellness” letter from Chris Wood, who has worked on a bunch of investment letters for different publishers, and Dr. Michael Roizen, who is a well-known wellness “guru” and works at the Cleveland Clinic. Aims to provide both stock picks for healthcare-related investments, and health tips for readers.
Yesterday I was writing about Jeff Brown and his tease of Akoustis Technologies (AKTS) as an RF filter company that should see increasing demand from 5G (each advancing wireless standard is more complex and requires more filters), and that brought this pitch from Chris Wood to mind. To be fair, this ad is not new. […]
High end small-cap disruptor-seeking newsletter, Chris Wood formerly recommended tech and biotech stocks for Casey Extraordinary Technology.
The ad we’re looking at today starts out with all sorts of braggadocio about how Jeff Brown at Bonner & Partners is “arrogant” or “pompous” and “egocentric” and “in your face,” and in general just not a very nice guy… the headline is “America’s Most Arrogant Investor.” That’s all malarkey — I don’t care whether […]
Let’s start with a little exercise… this is the pivotal sentiment of the latest pitch from Chris Wood in his ad for Casey’s Extraordinary Technology newsletter: “The Stock Story I’m About To Share With You Is The BIGGEST Of My Entire Career” How often, do you imagine, is something similar said in an ad for […]
This latest spiel from Casey Extraordinary Technology caught my eye because it includes so many silly enticements… the hint of mystery, the photo of the secret building that a big company never talks about, the connection to unusual world elites (a scale model hand delivered to Pope Francis” and, of course, “a technological breakthrough not […]
Chris Wood is out with an attention-getting ad for Casey’s Extraordinary Technology newsletter ($1,497 “on sale!”), and readers are asking their favorite neighborhood Gumshoe… so let’s get you some answers. The basic pitch is that there’s a kind of power that he calls “Bell Power,” and it’s growing like mad and could supply all our […]
Monthly newsletter highlighting technology and biotech stocks, previously edited by Alex Daley.